FERTILITY PRESERVATION – Adds to existing law to establish provisions regarding fertility preservation services.
Summary
House Bill 818 aims to amend Chapter 18, Title 41 of the Idaho Code by adding provisions that mandate coverage for certain fertility preservation services under health benefit plans. The bill defines 'fertility preservation services' to include the collection and preservation of sperm, unfertilized oocytes, and ovarian tissue, while explicitly excluding the storage of these genetic materials. It requires that health benefit plans providing medical or surgical expense coverage must include fertility preservation services for individuals undergoing medically necessary treatments for cancer that may impair fertility, as recognized by established medical guidelines.
Impact
The passage of this bill will establish a legal requirement for health insurance providers in Idaho to cover fertility preservation services for patients undergoing cancer treatments. This change will affect various health benefit plans, including those offered by insurance companies, managed care organizations, and fraternal benefit societies. By ensuring coverage for these services, the bill aims to protect the reproductive health of individuals facing fertility risks due to medical treatments.
Sentiment
The general sentiment surrounding House Bill 818 appears to be supportive, particularly among health advocates and organizations focused on reproductive health. There is recognition of the importance of preserving fertility for individuals undergoing cancer treatments, and the bill is seen as a necessary step in ensuring access to these critical services. However, specific discussions or votes have not been documented, indicating a potential lack of opposition or controversy at this stage.
Contention
While there are no documented points of contention in the available discussions or voting history, potential areas of debate could arise regarding the scope of coverage and the definitions of 'medically necessary treatments.' Stakeholders such as insurance companies may express concerns about the financial implications of mandated coverage, while health advocates may push for broader definitions to include more patients.